BP Targets in Renal Transplant Recipients: Too High or Too Low?

被引：2

作者：

Holdaas, Hallvard ^{[1
]}

Jardine, Alan G. ^{[2
]}

机构：

[1] Natl Hosp Norway, Oslo Univ Hosp, Dept Transplant Med, N-0424 Oslo, Norway

[2] Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland

来源：

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2014年 / 25卷 / 07期

关键词：

LEFT-VENTRICULAR HYPERTROPHY; BLOOD-PRESSURE CONTROL; COLLABORATIVE TRANSPLANT; KIDNEY-TRANSPLANTATION; CARDIOVASCULAR-DISEASE; PATIENT SURVIVAL; CONTROLLED-TRIAL; GRAFT-SURVIVAL; ACE-INHIBITOR; OUTCOMES;

D O I：

10.1681/ASN.2014020177

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1371 / 1373

页数：3

共 29 条

[1] [Anonymous], 2012, KIDNEY INT S2, Vl9, P370
[2] Homocysteine-Lowering and Cardiovascular Disease Outcomes in Kidney Transplant Recipients Primary Results From the Folic Acid for Vascular Outcome Reduction in Transplantation Trial
Bostom, Andrew G.
Carpenter, Myra A.
Kusek, John W.
Levey, Andrew S.
Hunsicker, Lawrence
Pfeffer, Marc A.
Selhub, Jacob
Jacques, Paul F.
Cole, Edward
Gravens-Mueller, Lisa
House, Andrew A.
Kew, Clifton
McKenney, Joyce L.
Pacheco-Silva, Alvaro
Pesavento, Todd
Pirsch, John
Smith, Stephen
Solomon, Scott
Weir, Matthew
[J]. CIRCULATION, 2011, 123 (16) : 1763 - 1770
[3] Arterial stiffness and pulse pressure in CKD and ESRD
Briet, Marie
Boutouyrie, Pierre
Laurent, Stephane
London, Gerard M.
[J]. KIDNEY INTERNATIONAL, 2012, 82 (04) : 388 - 400
[4] BP, Cardiovascular Disease, and Death in the Folic Acid for Vascular Outcome Reduction in Transplantation Trial
Carpenter, Myra A.
John, Alin
Weir, Matthew R.
Smith, Stephen R.
Hunsicker, Lawrence
Kasiske, Bertram L.
Kusek, John W.
Bostom, Andrew
Ivanova, Anastasia
Levey, Andrew S.
Solomon, Scott
Pesavento, Todd
Weiner, Daniel E.
[J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2014, 25 (07): : 1554 - 1562
[5] Patient survival after renal transplantation: I. The impact of dialysis pre-transplant
Cosio, FG
Alamir, A
Yim, S
Pesavento, TE
Falkenhain, ME
Henry, ML
Elkhammas, EA
Davies, EA
Bumgardner, GL
Ferguson, RM
[J]. KIDNEY INTERNATIONAL, 1998, 53 (03) : 767 - 772
[6] Angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor antagonist therapy is associated with prolonged patient and graft survival after renal transplantation
Heinze, Georg
Mitterbauer, Christa
Regele, Heinz
Kramar, Reinhard
Winkelmayer, Wolfgang C.
Curhan, Gary C.
Oberbauer, Rainer
[J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2006, 17 (03): : 889 - 899
[7] Regression of left ventricular hypertrophy by lisinopril after renal transplantation:: Role of ACE gene polymorphism
Hernández, D
Lacalzada, J
Salido, E
Linares, J
Barragán, A
Lorenzo, V
Higueras, L
Martín, B
Rodríguez, A
Laynez, I
González-Posada, JM
Torres, A
[J]. KIDNEY INTERNATIONAL, 2000, 58 (02) : 889 - 897
[8] Effect of fluvastatin on cardiac outcomes in renal transplant recipients:: a multicentre, randomised, placebo-controlled trial
Holdaas, H
Fellström, B
Jardine, AG
Holme, I
Nyberg, G
Fauchald, P
Grönhagen-Riska, C
Madsen, S
Neumayer, HH
Cole, E
Maes, B
Ambühl, P
Olsson, AG
Hartmann, A
Solbu, DO
Pedersen, TR
[J]. LANCET, 2003, 361 (9374) : 2024 - 2031
[9] Angiotensin II Blockade in Kidney Transplant Recipients
Ibrahim, Hassan N.
Jackson, Scott
Connaire, Jeffery
Matas, Arthur
Ney, Arthur
Najafian, Behzad
West, Ann
Lentsch, Nicole
Ericksen, Jensina
Bodner, Jenny
Kasiske, Bertram
Mauer, Michael
[J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2013, 24 (02): : 320 - 327
[10] The renin-aldosterone axis in kidney transplant recipients and its association with allograft function and structure
Issa, Naim
Ortiz, Fernando
Reule, Scott A.
Kukla, Aleksandra
Kasiske, Bertram L.
Mauer, Michael
Jackson, Scott
Matas, Arthur J.
Ibrahim, Hassan N.
[J]. KIDNEY INTERNATIONAL, 2014, 85 (02) : 404 - 415

← 1 2 3 →